The Ebola virus has posed significant public health challenges since its discovery. With outbreaks in Africa leading to high mortality rates, the need for effective vaccines has become paramount. In 2024, the Ebola vaccine market is witnessing notable developments driven by advancements in research, funding, and global collaboration. Read More
